Cargando…
Current methods in translational cancer research
Recent developments in pre-clinical screening tools, that more reliably predict the clinical effects and adverse events of candidate therapeutic agents, has ushered in a new era of drug development and screening. However, given the rapid pace with which these models have emerged, the individual meri...
Autores principales: | Lee, Michael W., Miljanic, Mihailo, Triplett, Todd, Ramirez, Craig, Aung, Kyaw L., Eckhardt, S. Gail, Capasso, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897192/ https://www.ncbi.nlm.nih.gov/pubmed/32929562 http://dx.doi.org/10.1007/s10555-020-09931-5 |
Ejemplares similares
-
Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms
por: Miljanic, Mihailo, et al.
Publicado: (2020) -
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
por: van der Haar Àvila, Irene, et al.
Publicado: (2023) -
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
por: Bidard, François-Clément, et al.
Publicado: (2012) -
Exosomes: a new perspective in EGFR-mutated lung cancer
por: Jouida, Amina, et al.
Publicado: (2021) -
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
por: van Loon, Karlijn, et al.
Publicado: (2020)